Skip to main content

Tiglutik Side Effects

Generic name: riluzole

Medically reviewed by Last updated on Sep 29, 2023.

Note: This document contains side effect information about riluzole. Some dosage forms listed on this page may not apply to the brand name Tiglutik.

Applies to riluzole: oral film, oral suspension, oral tablet.

Serious side effects of Tiglutik

Along with its needed effects, riluzole (the active ingredient contained in Tiglutik) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking riluzole:

Less common

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking riluzole:

Symptoms of overdose

Other side effects of Tiglutik

Some side effects of riluzole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to riluzole: oral film, oral suspension, oral tablet.


The most commonly reported adverse reactions have included asthenia, nausea, dizziness, decreased lung function, and abdominal pain.[Ref]


Very common (10% or more): At least 1 ALT elevation of above upper limit of normal (ULN)

Common (1% to 10%): ALT elevation above 5 x ULN

Rare (0.01% to 0.1%): Hepatitis, jaundice, hepatocellular damage

Frequency not reported: Drug-induced hepatic injury

Postmarketing reports: Acute hepatitis and icteric toxic hepatitis[Ref]

In clinical trials, ALT elevations above 5 times the upper limit of normal (5 X ULN) were reported in 2% of patients, about 50% had at least 1 elevated ALT, and 8% had at least one elevated ALT level above 3 x ULN. Drug-induced hepatic injury, including fatalities, have been reported.

Study data indicate that Asian patients may be more susceptible to liver function test abnormalities; 3.2% (194/5995) of Asian patients and 1.8% (100/5641) of Caucasian patients experienced liver function test abnormalities.[Ref]


There have been 3 reports (n=5000) of marked neutropenia where absolute neutrophil count was less than 500/mm3, all within first 2 months of treatment. In one case, neutrophil counts rose on continued treatment. In a second case, counts rose after therapy was stopped. A third case was associated with marked anemia with uncertain etiology[Ref]

Uncommon (0.1% to 1%): Anemia

Rare (0.01% to 0.1%): Erythropenia, leucopenia, thrombocytopenia

Very rare (less than 0.01%): Neutropenia[Ref]


Common (1% to 10%): Decreased lung function, increased cough,

Uncommon (0.1% to 1%): Respiratory failure, interstitial lung disease

Rare (0.01% to 0.1%): Asphyxia, respiratory distress.

Frequency not reported: Hypersensitivity pneumonitis


Very common (10% or more): Nausea (16%)

Common (1% to 10%): Abdominal pain, vomiting, dry mouth, flatulence

Uncommon (0.1% to 1%): Pancreatitis

Rare (0.01% to 0.1%): Gastrointestinal disorder, gastric ulcer, gastrointestinal hemorrhage, gastrointestinal irritation, melena[Ref]

Nervous system

In clinical trials, the incidence of dizziness was greater in females than males (11% vs 4%). There was no difference in rates of adverse reactions leading to discontinuation between genders.[Ref]

Common (1% to 10%): Dizziness, circumoral paresthesia, somnolence[Ref]


Very rare (less than 0.01%): Angioedema

Frequency not reported: Anaphylaxis


Common (1% to 10%): Insomnia

Rare (0.01% to 0.1%): Completed suicide, confusion, delirium, hallucination, personality change due to a general medical condition

Very rare (less than 0.01%): Amnesia


Postmarketing reports: Renal tubular impairment


Common (1% to 10%): Arthralgia[Ref]


Common (1% to 10%): Hypertension, tachycardia, peripheral edema

Rare (0.01% to 0.1%): Angina unstable, atrial fibrillation, cardiac failure

Very rare (less than 0.01%): Arrhythmia


Rare (0.01% to 0.1%): Dehydration

Very rare (less than 0.01%): Hyponatremia


Very common (10% or more): Asthenia (19%)

Common (1% to 10%): Vertigo, malaise, pyrexia


Common (1% to 10%): Pruritus, eczema

Rare (0.01% to 0.1%): Dermatitis


Common (1% to 10%): Urinary tract infection

Frequently asked questions


1. (2001) "Product Information. Rilutek (riluzole)." Rhone Poulenc Rorer

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.